GU104003: Dihydroartemisinin-12-α-O-β-D-Glucuronide Pack Size:5 mg 5-Trihydroxy-6-[4-(2-hydroxy-3-isopropylamino-propoxy)-naphthalen-1-yloxy]-tetrahydro-pyran-2-carboxylic acid

5-Trihydroxy-6-[4-(2-hydroxy-3-isopropylamino-propoxy)-naphthalen-1-yloxy]-tetrahydro-pyran-2-carboxylic acid

93 / An Fmoc-protected L-threonine building block carrying a GlcNAcβ1-3GalNAcα disaccharide

Neu5Acα2-6LacNAc is also a substrate for sialidases

used to build glycopeptides for cancer vaccine and anti-STn antibody research

/ Fmoc-Tyr(Gal(Ac)4-β-D)-OH / Fmoc-L-Tyr(Gal(Ac)4-β-D)-OH

GU104003: Dihydroartemisinin-12-α-O-β-D-Glucuronide Pack Size:5 mg 5-Trihydroxy-6-[4-(2-hydroxy-3-isopropylamino-propoxy)-naphthalen-1-yloxy]-tetrahydro-pyran-2-carboxylic acidC21H32O11 460. 47 Dihydroartemisinin 12 O D Glucuronide Dihydroartemisinin Glucuronide; (3R,5aS,6R,8aS,9S,12R,12aS) Decahydro 3,6,9 trimethyl 3,12 epoxy 12H pyrano[4,3 j] 1,2 benzodioxepin 10 yl D Glucopyranosiduronic Acid; Dihydroartemisinin Glucuronide